"Development of novel (i.e., not known to be naturally-occurring) GMOs exhibiting unique designer characteristics requires substantially greater knowledge and capability. Many industrialized nations have laboratories capable of analyzing which immune response modifier genes in humans and livestock, when inserted into an organism together with pathogenicity (e.g., adherence and invasive) factor, will yield highly infectious pathogenic organisms."